MEDICURE INC. Files August 2024 6-K Report
Ticker: MCUJF · Form: 6-K · Filed: Aug 15, 2024 · CIK: 1133519
| Field | Detail |
|---|---|
| Company | Medicure Inc (MCUJF) |
| Form Type | 6-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
MEDICURE INC. (MCUR) filed its monthly 6-K, confirming its foreign private issuer status.
AI Summary
On August 15, 2024, MEDICURE INC. filed a Form 6-K with the SEC. This report is for the month of August 2024 and indicates that the company is a foreign private issuer filing under the 1934 Act. MEDICURE INC. is based in Winnipeg, Canada, and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides routine updates for investors and the market regarding MEDICURE INC.'s status as a foreign private issuer. It confirms their ongoing reporting obligations with the SEC.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- MEDICURE INC. (company) — Registrant
- 0001654954-24-010678 (filing_id) — Accession Number
- 20240815 (date) — Filing Date
- Winnipeg, MB Canada (location) — Company Headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information for the month of August 2024, as required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, by MEDICURE INC., a foreign private issuer.
What is MEDICURE INC.'s standard industrial classification?
MEDICURE INC.'s standard industrial classification is Pharmaceutical Preparations [2834].
Where is MEDICURE INC. located?
MEDICURE INC. is located at 2-1250 Waverley Street, Winnipeg, MB Canada R3T 6C6.
Does MEDICURE INC. file annual reports under Form 20-F or Form 40-F?
MEDICURE INC. files annual reports under cover of Form 20-F.
Is MEDICURE INC. submitting this Form 6-K in paper format?
The filing indicates that MEDICURE INC. is not submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) or Rule 101(b)(7).
Filing Stats: 243 words · 1 min read · ~1 pages · Grade level 10.2 · Accepted 2024-08-14 17:42:29
Filing Documents
- med_6k.htm (6-K) — 11KB
- med_ex991.htm (EX-99.1) — 157KB
- med_ex991img3.jpg (GRAPHIC) — 3KB
- 0001654954-24-010678.txt ( ) — 173KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Medicure Inc. (Registrant) Date: August 14, 2024 By: /s/ Dr. Albert D. Friesen Dr. Albert D. Friesen Title: CEO 3